FDA Import Refusal 799-8026619-3/10003/1 — Merck Frosst Canada, Ltd.
The FDA refused shipment 799-8026619-3/10003/1 from Merck Frosst Canada, Ltd. (Canada) on Nov 19, 2025. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 19, 2025
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCB68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
- Charges
- 75